CapsoVision (CV) Cash & Equivalents (2024 - 2025)
CapsoVision recorded quarterly Cash & Equivalents of $10.1 million in Q4 2025, down 43.15% quarter-over-quarter from $17.8 million in Q3 2025, and up 8.51% year-over-year from $9.3 million in Q4 2024.
CapsoVision's Cash & Equivalents history runs 2 years deep, the most recent figure standing at $10.1 million for Q4 2025.
- In Q4 2025, Cash & Equivalents rose 8.51% year-over-year to $10.1 million; the TTM figure through Dec 2025 stood at $10.1 million (up 8.51% YoY), while the FY2025 annual figure was $10.1 million, up 8.51% from the prior year.
- Cash & Equivalents came in at $10.1 million for Q4 2025 at CapsoVision, down from $17.8 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $17.8 million in Q3 2025 to a low of $1.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.03 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1.12 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 439.60 Mn |
| 10 | CapsoVision | 167.59 Mn | 157.48 Mn | 1.95 Mn | 10.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.11 Mn |
| Sep 30, 2025 | 17.79 Mn |
| Jun 30, 2025 | 1.07 Mn |
| Dec 31, 2024 | 9.32 Mn |